secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001213900-25-054784
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx stockholders elect five directors, approve say-on-pay at 2025 annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected; Catherine Klema received most votes (11,050,447 for).
- Advisory say-on-pay approved with 5,443,720 in favor vs 3,857,653 against and 3,757,636 abstentions.
- Ratification of UHY LLP as auditor approved with 15,162,244 votes for.
- Total shares outstanding 18,493,447; broker non-votes of 2,874,955 on director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390025054784/0001213900-25-054784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390025054784/ea0245924-8k_optimize.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-054784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer